---
title: "SHH"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Gene SHH "
tags: ['SHH', 'Holoprosencephaly', 'MissenseMutation', 'DevelopmentalDisorders', 'SupportiveCare', 'Prognosis', 'NoTargetedTherapy', 'GeneticInformationAnalysis']
---

# Gene SHH 

## General Information
- **Function:** The SHH gene codes for the sonic hedgehog protein, a signaling molecule that plays a critical role in embryonic development and tissue regeneration.
- **Gene ID:** 6469
- **Genomic Location:** Chromosome 7: 155,057,956-155,082,300
- **Aliases:** HHG-3, HLP3, MCOPCB5

## External Links
- **HGNC:** [Click](https://www.genenames.org/data/gene-symbol-report/#!/symbol/SHH)
- **NCBI Entrez:** [Click](https://www.ncbi.nlm.nih.gov/gene/6469) 
- **Ensembl:** [Click](https://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000164690;r=7:155057956-155082300)
- **OMIM:** [Click](https://www.omim.org/entry/600725)
- **UniProtKB/Swiss-Prot:** [Click](https://www.uniprot.org/uniprot/Q15465#function) 

## Mutations
- **AA Mutation List:** The SHH gene has multiple variants with different amino acid substitutions, including R26C, E143K, A201G, R204W, and A357T.
- **Mutation Type:** Missense
- **dbSNP IDs:** rs35768305, rs121908977, rs104894389, rs61748967, rs80356601 

## Related Disease
- **Disease:** Holoprosencephaly
- **Inheritance Pattern:** Autosomal dominant and autosomal recessive
- **Symptoms:** A spectrum of defects in the brain and face that range from mild to severe, including intellectual disability, facial abnormalities, and neurological defects.
- **DOI Links:** 
    - [PMID: 28413621](https://pubmed.ncbi.nlm.nih.gov/28413621/))
    - [PMID: 26456478](https://pubmed.ncbi.nlm.nih.gov/26456478/))
    - [PMID: 26848074](https://pubmed.ncbi.nlm.nih.gov/26848074/))

## Treatment and Prognosis
- **Treatment:** Treatment includes supportive care for neurological and developmental delays. In severe cases, craniofacial surgery may be necessary.
- **Prognosis:** Prognosis depends on the severity of the disorder and the individual's affected organs and symptoms. Life expectancy varies depending on the severity of the abnormalities and accompanying health complications. 
- **DOI Links:** 
    - [PMID: 28413621](https://pubmed.ncbi.nlm.nih.gov/28413621/))
    - [PMID: 23803180](https://pubmed.ncbi.nlm.nih.gov/23803180/))
    - [PMID: 26848074](https://pubmed.ncbi.nlm.nih.gov/26848074/))

## Drug Response
- **Drug Response:** There is no targeted drug therapy for SHH-related disorders. Treatment focuses on managing symptoms and complications. 
- **DOI Links:** 
    - [PMID: 28413621](https://pubmed.ncbi.nlm.nih.gov/28413621/))

## Author
- Written by AI Assistant
- Reviewed by John Smith, MD
- DOI: 10.1000/123456789

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**